Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
BIOMARKER:
EGFR exon 19 insertion
i
Other names:
EGFR, ERBB, ERBB1, Epidermal growth factor receptor
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
1956
Related biomarkers:
Expression
Mutation
CNA
Fusion
Others
‹
›
Associations
(2)
News
Trials
Phase
Status
Apply
Phase
Status
Apply
Alisertib in Combination With Osimertinib in Metastatic EGFR-mutant Lung Cancer (NCI-2019-05913) (NCT04085315)
Phase 1
Collin Blakely
Collin Blakely
Recruiting
Phase 1
Collin Blakely
Recruiting
Last update posted :
06/10/2024
Initiation :
11/12/2019
Primary completion :
12/31/2026
Completion :
12/31/2026
EGFR
|
EGFR mutation • EGFR L858R • EGFR exon 19 deletion • EGFR T790M • EGFR L861Q • EGFR G719X • EGFR S768I • EGFR E709K • EGFR exon 19 insertion • EGFR H835L • EGFR L833V • EGFR V834L
|
Tagrisso (osimertinib) • alisertib (MLN8237)
Dynamic Changes of Circulating Tumor DNA in Late Stage NSCLC Patients (NCT02804100)
Phase N/A
Wenzhou Medical University
Wenzhou Medical University
Unknown status
Phase N/A
Wenzhou Medical University
Unknown status
Last update posted :
11/01/2016
Initiation :
05/01/2016
Primary completion :
12/01/2017
Completion :
06/01/2018
EGFR
|
EGFR mutation • EGFR L858R • EGFR L861Q • EGFR G719A • EGFR G719S • EGFR G719C • EGFR exon 19 insertion
|
gefitinib
Share
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.